CoChat

Machine learning for the prediction of toxicities from head and neck cancer treatment: A systematic review with meta-analysis

Araújo, Anna Luíza Damaceno, Moraes, Matheus Cardoso, Pérez-de-Oliveira, Maria Eduarda, Silva, Viviane Mariano da, Saldivia-Siracusa, Cristina, Pedroso, Caique Mariano, Lopes, Marcio Ajudarte, Vargas, Pablo Agustin, Kochanny, Sara, Pearson, Alexander, Khurram, Syed Ali, Kowalski, Luiz Paulo, Migliorati, Cesar Augusto, Santos-Silva, Alan Roger · 2023 · Oral Oncology
Cited by 36

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

INTRODUCTION The aim of the present systematic review (SR) is to summarize Machine Learning (ML) models currently used to predict head and neck cancer (HNC) treatment-related toxicities, and to understand the impact of image biomarkers (IBMs) in prediction models (PMs). The present SR was conducted following the guidelines of the PRISMA 2022 and registered in PROSPERO database (CRD42020219304). METHODS The acronym PICOS was used to develop the focused review question (Can PMs accurately predict HNC treatment toxicities?) and the eligibility criteria. The inclusion criteria enrolled Prediction Model Studies (PMSs) with patient cohorts that were treated for HNC and developed toxicities. Electronic database search encompassed PubMed, EMBASE, Scopus, Cochrane Library, Web of Science, LILACS, and Gray Literature (Google Scholar and ProQuest). Risk of Bias (RoB) was assessed through PROBAST and the results were synthesized based on the data format (with and without IBMs) to allow comparison. RESULTS A total of 28 studies and 4,713 patients were included. Xerostomia was the most frequently investigated toxicity (17; 60.71 %). Sixteen (57.14 %) studies reported using radiomics features in combination with clinical or dosimetrics/dosiomics for modelling. High RoB was identified in 23 studies. Meta-analysis (MA) showed an area under the receiver operating characteristics curve (AUROC) of 0.82 for models with IBMs and 0.81 for models without IBMs (p value < 0.001), demonstrating no difference among IBM- and non-IBM-based models. DISCUSSION The development of a PM based on sample-specific features represents patient selection bias and may affect a model's performance. Heterogeneity of the studies as well as non-standardized metrics prevent proper comparison of studies, and the absence of an independent/external test does not allow the evaluation of the model's generalization ability. CONCLUSION IBM-featured PMs are not superior to PMs based on non-IBM predictors. The evidence was appraised as of low certainty.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.oraloncology.2023.106386

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 36

Metadata

Authors
Araújo, A. L. D., Moraes, M. C., Pérez-de-Oliveira, M. E., Silva, V. M. D., Saldivia-Siracusa, C., Pedroso, C. M., Lopes, M. A., Vargas, P. A., Kochanny, S., Pearson, A., Khurram, S. A., Kowalski, L. P., Migliorati, C. A., & Santos-Silva, A. R.
Venue
Oral Oncology
Publisher
Elsevier BV
Published
2023-05
Volume
140
Pages
106386
ISSN
1368-8375 (ISSN-L)
OpenAlex
W4362631144
Cited by
36
References
11
FWCI
2.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Machine learning for the prediction of toxicities from head and neck cancer treatment: A systematic review with meta-analysis. https://app.cochat.ai/papers/10.1016/j.oraloncology.2023.106386
The paper
Araújo, A. L. D., Moraes, M. C., Pérez-de-Oliveira, M. E., Silva, V. M. D., Saldivia-Siracusa, C., Pedroso, C. M., Lopes, M. A., Vargas, P. A., Kochanny, S., Pearson, A., Khurram, S. A., Kowalski, L. P., Migliorati, C. A., & Santos-Silva, A. R. (2023). Machine learning for the prediction of toxicities from head and neck cancer treatment: A systematic review with meta-analysis. Oral Oncology. https://doi.org/10.1016/j.oraloncology.2023.106386

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.